Drug intelligence / Profile preview

proanthocyanidin-rich extract

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Proanthocyanidin-rich extract is a natural plant-derived mixture concentrated in proanthocyanidins, a subclass of polyphenolic flavonoids formed by oligomers and polymers of catechins and epicatechins. These extracts are widely sourced from grape seed, but also from the peel, seeds, and leaves of fruits such as cranberry, bilberry, and others. Proanthocyanidin-rich extracts exhibit antioxidant, anti-inflammatory, anti-cancer, anti-atherosclerotic, hypoglycemic, antihypertensive, neuroprotective, and anti-ageing activities, and are also involved in regulation of lipid and glucose metabolism, and the modulation of signaling pathways associated with chronic diseases. The mechanism of action is largely attributed to ROS scavenging, modulation of signaling pathways (e.g., NF-κB, AMPK/mTOR/p70S6K, PI3K/Akt), suppression of pro-inflammatory cytokine expression, inhibition of xanthine oxidase, regulation of macrophage polarization, downregulation of cyclooxygenase-2, and stabilization of endothelial and epithelial tight junctions. The extract is used primarily as a dietary supplement and investigated for cardiovascular, metabolic, neurodegenerative, inflammatory, and bone health indications, as well as cosmetic purposes[1][2][3][4][5][6][7].

Other names
proanthocyanidin-rich grape seed extractPAC-rich extractoligomeric proanthocyanidin complexesgrape seed extractgrape seed proanthocyanidinsoligomeric proanthocyanidinsOPCprocyanidolic oligomersproanthocyanidinsanthocyanidinanthocyanadinsanthocyanincelphinidincyanidindelphinidinmalvidinpelargonidinpeonidinpetunidin
02

Targets

XO (Xanthine Oxidoreductase)AMPK (Adenosine monophosphate–activated protein kinase)

Beyond the preview

Go deeper on proanthocyanidin-rich extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on proanthocyanidin-rich extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call